We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$17.2B
AUM Growth
+$1.4B
Cap. Flow
+$543M
Cap. Flow %
3.15%
Top 10 Hldgs %
62.73%
Holding
1,140
New
150
Increased
453
Reduced
383
Closed
150

Top Sells

Rank Stock Value
1
ENLC
ENLINK MIDSTREAM, LLC
ENLC
+$706M
2
CCJ icon
Cameco
CCJ
+$31.2M
3
FSM icon
Fortuna Silver Mines
FSM
+$12M
4
MPLX icon
MPLX
MPLX
+$11.4M
5
UEC icon
Uranium Energy
UEC
+$10.8M

Sector Composition

Rank Sector Weight
1 Energy 69.95%
2 Technology 3.96%
3 Financials 3.32%
4 Consumer Discretionary 3%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRS icon
976
Aclaris Therapeutics
ACRS
$753M
$121K ﹤0.01%
78,782
+21,022
+36% +$44.8K
NMRA icon
977
Neumora Therapeutics
NMRA
$293M
$114K ﹤0.01%
114,371
-16,273
-12% -$27.9K
FDMT icon
978
4D Molecular Therapeutics
FDMT
$536M
$106K ﹤0.01%
32,811
-4,568
-12% -$21.5K
LRMR icon
979
Larimar Therapeutics
LRMR
$400M
$102K ﹤0.01%
47,460
-4,130
-8% -$13.1K
ALEC icon
980
Alector
ALEC
$169M
$92.2K ﹤0.01%
74,933
-4,182
-5% -$6.81K
ENTA icon
981
Enanta Pharmaceuticals
ENTA
$377M
$89.7K ﹤0.01%
16,257
-880
-5% -$5.44K
ZNTL icon
982
Zentalis Pharmaceuticals
ZNTL
$320M
$87.5K ﹤0.01%
55,033
-2,554
-4% -$5.51K
PROK icon
983
ProKidney
PROK
$316M
$83.4K ﹤0.01%
95,182
-8,295
-8% -$11.5K
KYTX icon
984
Kyverna Therapeutics
KYTX
$482M
$62K ﹤0.01%
32,126
-2,786
-8% -$8.23K
MGNX icon
985
MacroGenics
MGNX
$249M
$61.8K ﹤0.01%
48,646
-2,104
-4% -$5.5K
PLRX icon
986
Pliant Therapeutics
PLRX
$66.9M
$61.1K ﹤0.01%
45,261
-3,949
-8% -$24K
ATLX icon
987
Atlas Lithium Corp
ATLX
$83.5M
$55.7K ﹤0.01%
+10,779
New +$64.1K
CRML icon
988
Critical Metals Corp
CRML
$861M
$51.2K ﹤0.01%
36,799
+21,451
+140% +$97.8K
STRO icon
989
Sutro Biopharma
STRO
$394M
$39.9K ﹤0.01%
6,127
-538
-8% -$8.47K
ABAT icon
990
American Battery Technology Co
ABAT
$303M
$30.9K ﹤0.01%
30,028
+5,490
+22% +$7.45K
AAON icon
991
Aaon
AAON
$8.07B
-3,734
Closed -$439K
ACGL icon
992
Arch Capital
ACGL
$36.5B
-3,132
Closed -$289K
ACIW icon
993
ACI Worldwide
ACIW
$5.84B
-7,300
Closed -$379K
AFL icon
994
Aflac
AFL
$64.4B
-3,250
Closed -$336K
AIZ icon
995
Assurant
AIZ
$13.8B
-1,850
Closed -$394K
AKAM icon
996
Akamai
AKAM
$16.4B
-3,600
Closed -$344K
ALL icon
997
Allstate
ALL
$67.4B
-1,900
Closed -$366K
ALSN icon
998
Allison Transmission
ALSN
$9.91B
-4,082
Closed -$441K
AMAT icon
999
Applied Materials
AMAT
$393B
-1,889
Closed -$307K
AMP icon
1000
Ameriprise Financial
AMP
$47.6B
-800
Closed -$426K

Similar funds

ALPS Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, ALPS Advisors held 1,140 positions worth $17.2B, up 8.8% from $15.8B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ALPS Advisors deployed $543M of net new capital in Q1 2025, opening 150 new positions and adding to 453 existing holdings. Its largest new stake was Sprott Physical Silver Trust: 763,746 shares worth $8.86M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 69% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cameco, an estimated $31.2M trimmed.

  • ALPS Advisors's largest Q1 2025 buy was Sprott Physical Silver Trust: 763,746 shares worth $8.86M.
  • ALPS Advisors added most to Hess Midstream in Q1 2025, an estimated $255M increase.
  • ALPS Advisors's biggest Q1 2025 reduction was Cameco, cutting an estimated $31.2M.
  • ALPS Advisors fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $706M.
  • ALPS Advisors's ten largest holdings make up 63% of its $17.2B portfolio in Q1 2025.
  • ALPS Advisors opened 150 new positions and closed 150 in Q1 2025.
  • ALPS Advisors's portfolio value rose 8.8% quarter-over-quarter to $17.2B.

Based on ALPS Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.